Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here


Rutgers Scientists Working on CRISPR Technology That Could, Literally, Change the World

New Brunswick, NJ, October 21, 2017 — CRISPR…what’s that?  Senior correspondent David Cruz reports on “NJTV News” that CRISPR is emerging technology that you might be hearing about it yet have little understanding that it has the potential to change pretty much everything and everyone in the world.

Peter Romanienko, the managing director of the Genome Editing Core Facility at Rutgers University, explained, “CRISPR is a programmable nucleus, so the power of it is.

And what makes it work so well for gene editing and some of the techniques we use is this protein can use this small segment of RNA to find a site in the genome and cut it.  And by making this DNA break in the genome is what allows us to introduce sequences and repair.” Continue reading

NJTV News: Specialty Drugs Cost More Than Most Yearly Incomes; HINJ CEO Interviewed

NJTV News w Mary Alice WilliamsNewark, NJ, December 7, 2015 ― In a segment broadcast on December 4, NJTV News correspondent Erin Delmore explored prescription drug prices in the US. and consumer concerns.

Assemblyman Daniel Benson (D-14), Vice Chair of the Health & Senior Services Committee, says mounting drug prices — including Turing Pharmaceuticals’ hiking a lifesaving medication by 5,000 percent — have prompted concerned New Jerseyans to call his office, even if they have insurance.

“What we’re hearing, for the most part is: ‘I’ve bought insurance, I’m paying these large premiums per month and I still can’t get the drugs that I need to have a quality, a frame of life, because the co-pays are so high,’” Benson told Delmore. Continue reading